Revvity earnings were $239.7M for the trailing 12 months ending Apr 5, 2026, with -11.5% growth year over year. The latest RVTY earnings report on Apr 5, 2026 announced Q2 2026 earnings of $40.7M, down 58.6% from last quarter. For the last reported fiscal year 2025 ending Dec 28, 2025, RVTY reported annual earnings of $241.2M, with -10.8% growth.
RVTY past earnings growth
How has RVTY's earnings growth performed historically?
On RVTY's earnings call on Invalid Date, Revvity (NYSE: RVTY) reported Q1 2026 earnings per share (EPS) of $0.36, up 2.86% year over year. Total RVTY earnings for the quarter were $40.72 million. In the same quarter last year, Revvity's earnings per share (EPS) was $0.35.
As of the last Revvity earnings report, Revvity is currently profitable. Revvity's net profit (also called net income) for the twelve months ending Apr 5, 2026 was $239.68 million, a 16.37% decrease year over year.
What was RVTY's earnings growth in the past year?
As of Revvity's earnings date in Invalid Date, Revvity's earnings has grown -11.49% year over year. This is 21.99 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 10.5%. RVTY earnings in the past year totalled $239.68 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.